Negative regulation of platelet aggregation

pathway activity — cross-omics
GO:0090331Cross-omicsRNA → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of platelet aggregation pathway is significantly associated with the RNA expression of multiple genes, with the SCLC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are C1QTNF1, SH2B3, and SERPINE2, each associated with the pathway in up to 26 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of platelet aggregation activity versus C1QTNF1 in SCLC (Pearson r = 0.33).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
SCLCC1QTNF1 →+1.946+0.181<.001<.001326
SKCMSH2B3 →+0.714+0.045<.001<.001323
CHOLSERPINE2 →+2.974+0.102<.001<.001323
LIHCAEBP1 →+1.608+0.056<.001<.001322
CHOLMMP19 →+1.410+0.075.002.005124
CHOLTHBS1 →+2.762+0.101<.001.001322
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0090331 vs C1QTNF1 — SCLC

Per-sample scatter of Negative regulation of platelet aggregation activity vs C1QTNF1 in SCLC.

Explore this scatter interactively →

Exploration